论文部分内容阅读
用中药制剂固本生血丸加康力龙等西药治疗慢性再生障碍性贫血３０例，与单用康力龙等西药组进行对照、疗效明显优于对照组，２组同时进行抗马利兰诱发小鼠骨髓造血障碍作用试验，治疗组在降低死亡率及降低骨髓造血障碍发生率方面明显优于对照组。
Thirty cases of chronic aplastic anemia were treated with traditional Chinese medicines such as Gubenshengxuewan plus stanozolol and other Western medicines. The effect was better than that of the control group with Kanglilong and other Western medicine groups. The anti-Mileland induced bone marrow hematopoietic dysfunction was induced in both groups simultaneously. In the trial, the treatment group was significantly better than the control group in reducing mortality and reducing the incidence of bone marrow hematopoietic disorders.